...
首页> 外文期刊>Transplantation: Official Journal of the Transplantation Society >Attenuating Ischemia-Reperfusion Injury in Kidney Transplantation by Perfusing Donor Organs With siRNA Cocktail Solution
【24h】

Attenuating Ischemia-Reperfusion Injury in Kidney Transplantation by Perfusing Donor Organs With siRNA Cocktail Solution

机译:通过用siRNA鸡尾酒溶液灌注供体器官减轻肾脏移植中的缺血再灌注损伤。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Background. Ischemia-reperfusion (I/R) injury is the major cause of delayed renal graft function in kidney transplantation. To date, there are no effective therapeutic approaches for preventing I/R injury. We previously reported that treatment of animals with small interference RNA (siRNA) would prevent warm I/R injury in nontransplant models and cold I/R injury in heart transplantation. In the present study, we further explore the feasibility of protecting grafts from extended cold I/R injury as applied to kidney transplantation by downregulating I/R-associated genes using siRNA. Methods. Donor kidneys were intra-arterially perfused with siRNA containing solution during donor excision and preserved in siRNA containing solution. The siRNA-treated donor organs were then implanted into syngeneic recipient mice, and the 2 original kidneys were removed fromthe recipient. The effect of siRNA solution on extended cold I/R injury was determined by assessing renal function, histopathological change, cell apoptosis, and inflammation. Results. The perfused siRNA solution knocked down the expression of complement 3, RelB, and Fas in the kidney at the mRNA and protein levels. Administration of siRNA solution reduced the levels of blood urea nitrogen and serum creatinine as compared with control groups. The siRNA cocktail decreased cell apoptosis and histopathological changes in the kidney and prolonged graft survival. The siRNA cocktail also reduced the expression of proinflammatory cytokines, IL-6, and TNF alpha. Conclusions. In conclusion, this is the first demonstration that perfusing donor organs with an siRNA cocktail solution can induce gene silencing in the kidney and prevent kidneys from extended cold I/R injury in kidney transplantation, highlighting the promise of the clinical application of siRNA-based therapies in the preservation of donor organs.
机译:背景。缺血再灌注(I / R)损伤是肾移植中肾移植物功能延迟的主要原因。迄今为止,还没有预防I / R损伤的有效治疗方法。我们以前曾报道过,用小干扰RNA(siRNA)治疗动物可预防非移植模型中的温暖I / R损伤和心脏移植中的寒冷I / R损伤。在本研究中,我们进一步探索了通过使用siRNA下调I / R相关基因来保护移植物免受长期冷I / R损伤(如应用于肾脏移植)的可行性。方法。在供体切除期间,用含siRNA的溶液对供体肾脏进行动脉内灌注,并保存在含siRNA的溶液中。然后将经过siRNA处理的供体器官植入同种受体小鼠中,并从受体中取出2个原始肾脏。通过评估肾功能,组织病理学变化,细胞凋亡和炎症来确定siRNA溶液对长期感冒I / R损伤的影响。结果。灌注的siRNA溶液在mRNA和蛋白质水平上敲低了肾脏中补体3,RelB和Fas的表达。与对照组相比,siRNA溶液的给药降低了血尿素氮和血清肌酐的水平。 siRNA鸡尾酒减少了肾脏的细胞凋亡和组织病理学变化,并延长了移植物存活时间。 siRNA混合物还降低了促炎细胞因子,IL-6和TNFα的表达。结论。总之,这是第一个证明,在siRNA混合溶液中灌注供体器官可以诱导肾脏中的基因沉默,并防止肾脏在肾脏移植过程中长期受冷I / R损伤,这突出了基于siRNA疗法的临床应用前景在保存供体器官中。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号